Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

NACompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

March 31, 2025

Conditions
HIV InfectionsSyphilis
Interventions
DIAGNOSTIC_TEST

Cepheid GeneXpert HIV-1 Qual POC HIV VL test

POC Nucleic acid-based test for HIV RNA.

DIAGNOSTIC_TEST

DPP HIV-Syphilis test system

POC Tests for antibodies to HIV 1/2 and Treponema pallidum.

DIAGNOSTIC_TEST

OraQuick

POC oral fluid swab test for HIV 1/2 antibodies.

Trial Locations (3)

21217

The Baltimore City Health Department (BCHD) Health and Wellness Center, Sexual Health Clinics, Baltimore

21287

Johns Hopkins Hospital Emergency Department (JHHED), Baltimore

The John G. Bartlett Specialty Practice (JGBSP), Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Roche Molecular Systems, Inc

INDUSTRY

collaborator

Cepheid

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04793750 - Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC) | Biotech Hunter | Biotech Hunter